S&P 500   4,425.00 (+1.57%)
DOW   34,664.84 (+1.07%)
QQQ   351.55 (+1.87%)
AAPL   162.70 (+1.83%)
MSFT   300.60 (+4.20%)
FB   300.79 (+0.21%)
GOOGL   2,620.42 (+3.22%)
AMZN   2,816.00 (+0.58%)
TSLA   949.05 (+3.34%)
NVDA   232.05 (+3.95%)
BABA   116.85 (-1.92%)
NIO   23.57 (-0.92%)
AMD   113.36 (+2.01%)
CGC   7.47 (+1.49%)
MU   83.19 (+3.06%)
GE   90.63 (-0.53%)
T   25.70 (-2.95%)
F   20.29 (+1.55%)
DIS   137.22 (+0.52%)
AMC   16.28 (+1.62%)
PFE   53.02 (+0.91%)
ACB   4.23 (+0.48%)
BA   198.38 (-2.80%)
S&P 500   4,425.00 (+1.57%)
DOW   34,664.84 (+1.07%)
QQQ   351.55 (+1.87%)
AAPL   162.70 (+1.83%)
MSFT   300.60 (+4.20%)
FB   300.79 (+0.21%)
GOOGL   2,620.42 (+3.22%)
AMZN   2,816.00 (+0.58%)
TSLA   949.05 (+3.34%)
NVDA   232.05 (+3.95%)
BABA   116.85 (-1.92%)
NIO   23.57 (-0.92%)
AMD   113.36 (+2.01%)
CGC   7.47 (+1.49%)
MU   83.19 (+3.06%)
GE   90.63 (-0.53%)
T   25.70 (-2.95%)
F   20.29 (+1.55%)
DIS   137.22 (+0.52%)
AMC   16.28 (+1.62%)
PFE   53.02 (+0.91%)
ACB   4.23 (+0.48%)
BA   198.38 (-2.80%)
S&P 500   4,425.00 (+1.57%)
DOW   34,664.84 (+1.07%)
QQQ   351.55 (+1.87%)
AAPL   162.70 (+1.83%)
MSFT   300.60 (+4.20%)
FB   300.79 (+0.21%)
GOOGL   2,620.42 (+3.22%)
AMZN   2,816.00 (+0.58%)
TSLA   949.05 (+3.34%)
NVDA   232.05 (+3.95%)
BABA   116.85 (-1.92%)
NIO   23.57 (-0.92%)
AMD   113.36 (+2.01%)
CGC   7.47 (+1.49%)
MU   83.19 (+3.06%)
GE   90.63 (-0.53%)
T   25.70 (-2.95%)
F   20.29 (+1.55%)
DIS   137.22 (+0.52%)
AMC   16.28 (+1.62%)
PFE   53.02 (+0.91%)
ACB   4.23 (+0.48%)
BA   198.38 (-2.80%)
S&P 500   4,425.00 (+1.57%)
DOW   34,664.84 (+1.07%)
QQQ   351.55 (+1.87%)
AAPL   162.70 (+1.83%)
MSFT   300.60 (+4.20%)
FB   300.79 (+0.21%)
GOOGL   2,620.42 (+3.22%)
AMZN   2,816.00 (+0.58%)
TSLA   949.05 (+3.34%)
NVDA   232.05 (+3.95%)
BABA   116.85 (-1.92%)
NIO   23.57 (-0.92%)
AMD   113.36 (+2.01%)
CGC   7.47 (+1.49%)
MU   83.19 (+3.06%)
GE   90.63 (-0.53%)
T   25.70 (-2.95%)
F   20.29 (+1.55%)
DIS   137.22 (+0.52%)
AMC   16.28 (+1.62%)
PFE   53.02 (+0.91%)
ACB   4.23 (+0.48%)
BA   198.38 (-2.80%)
OTCMKTS:SKYE

Skye Bioscience News Headlines

$0.05
0.00 (-7.33%)
(As of 01/25/2022 03:54 PM ET)
Add
Compare
Today's Range
$0.04
$0.06
50-Day Range
$0.05
$0.08
52-Week Range
$0.04
$0.26
Volume
2.32 million shs
Average Volume
1.59 million shs
Market Capitalization
$22.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.39
Get Skye Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for SKYE and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Skye Bioscience Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SKYE
News Sentiment

0.00

0.33

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SKYE Articles
This Week

0

0

SKYE Articles
Average Week



Skye Bioscience (OTCMKTS:SKYE) News Headlines Today

SourceHeadline
MarketBeat logoSkye Bioscience, Inc. (OTCMKTS:SKYE) Short Interest Down 93.7% in December
americanbankingnews.com - January 13 at 4:54 PM
proactiveinvestors.com logoSkye Bioscience CEO Punit Dhillon says company 'fast approaching' first-in-human Phase I study in 2022 for SBI-100
proactiveinvestors.com - January 10 at 2:26 PM
finance.yahoo.com logoSkye Bioscience to Present at H.C. Wainwright BIOCONNECT Virtual Conference
finance.yahoo.com - January 4 at 9:18 AM
finance.yahoo.com logoSkye Bioscience Announces $7.0 Million Registered Direct Offering
finance.yahoo.com - September 27 at 11:34 AM
finance.yahoo.com logoSkye Bioscience Announces THCVHS Late-Breaking Preclinical Abstracts Selected by American Association of Pharmaceutical Scientists Meeting PharmSci 360
finance.yahoo.com - September 21 at 9:58 AM
finance.yahoo.com logoSkye Bioscience Completes THCVHS IND-enabling In Vitro Genotoxicity Studies
finance.yahoo.com - August 10 at 10:00 AM
bloomberg.com logoSkye Bioscience Inc
bloomberg.com - July 23 at 11:48 PM
Get Skye Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for SKYE and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/26/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.